RETAIL PHARMACY CASE STUDY:
12:00 pm Reimbursement of Point-of-Care Testing in a Retail Health Clinic Setting
12:00 pm Reimbursement of Point-of-Care Testing in a Retail Health Clinic Setting
Daniel R. Kerls, MBA, OTR/L, Director, Ambulatory Operations, CVS MinuteClinic
This presentation will focus on how point of care labs influence overall reimbursement in a retail health setting and provide an overview of current challenges and opportunities, as well as considerations of supplies and control testing.
CAPABILITIES OF PHARMACIES
1:50 Chairperson’s Opening Remarks
Allison M. Dering-Anderson, BA, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy, University of Nebraska College of Pharmacy
2:00 Community Pharmacies: The Face of Neighborhood Healthcare
Alex J. Adams, Pharm.D., IOM, Vice President, Pharmacy Programs, National Association of Chain Drug Stores (NACDS)
Community pharmacists are among the most accessible and trusted healthcare professionals; 95% of all Americans live within 5 miles of a pharmacies. Increasingly the public is turning to pharmacies for expanded services such as immunizations and point-of-care tests. This session will describe the community pharmacy landscape and opportunities to bring tests truly to the point-of-care.
2:30 Utilizing Pharmacists in Point-of-Care Testing: Scope of Practice Opportunities and Barriers
Krystalyn K. Weaver, Pharm.D., RPh, Director, Policy and State Relations, National Alliance of State Pharmacy Associations
This session will provide information on pharmacists’ education and training as it relates to point-of-care testing. An overview will be provided on how state laws and regulations that define pharmacist scope of practice create opportunities and barriers for the implementation of point-of-care testing programs in community pharmacies.
EXPLORING PHARMACY NEEDS AND DIAGNOSTIC CAPABILITIES
KEY INFORMANT INTERVIEWS:
3:00 Key Informant Interviews: Preliminary Results and Next Steps
3:00 Key Informant Interviews: Preliminary Results and Next Steps
Kenneth C. Hohmeier, Pharm.D., Assistant Professor, Clinical Pharmacy; Director, Community Affairs, College of Pharmacy, University of Tennessee
This session will present preliminary results from key informant interviews of diagnostic test manufacturers and pharmacy leaders. Manufacturers will have an opportunity to ask questions about the pharmacy market and pharmacy representatives will provide insight into the needs of the pharmacy market. The session will also include an opportunity for the audience to inform future interviews.
Harry Glorikian, Senior Executive/Board Director/Healthcare Consultant
Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy
Allison M. Dering-Anderson, BA, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy, University of Nebraska College of Pharmacy
5:15 The Shifting Landscape of Diagnostic Testing
Harry Glorikian, Senior Executive/Board Director/Healthcare Consultant
Diagnostic technology is continually evolving to meet changing models of care. This talk will discuss the trends driving the shift of where testing is performed. We will also discuss existing and emerging technologies in relation to diagnostics. We will discuss CLIA-waived tests and rapid tests that don’t require extensive processing but also other emerging trends that affect patient care and management. Finally, potential clinical and business opportunities for this market will be addressed.
5:45 What Tests Are Currently Available and Do They Fit into a Community Pharmacy Practice
Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy
The emerging market to use of CLIA-waived POC tests in community pharmacies will be discussed. Existing and developing care models will be explored. A review of test characteristics that would be attractive for pharmacy use will be provided. Opportunities and barriers for implementation of CLIA-waived POC test integrated care models will be explored.
THE BUSINESS OF HEALTHCARE: SOCIAL, ECONOMIC, AND LEGAL IMPLICATIONS
10:55 Chairperson’s Opening Remarks
Donald G. Klepser, Ph.D., MBA, Associate Professor, Pharmacy Practice, University of Nebraska Medical Center
11:00 Point-of-Care Diagnostics: Business Case and Patient Perceptions
Donald G. Klepser, Ph.D., MBA, Associate Professor, Pharmacy Practice, University of Nebraska Medical Center
This program will discuss research studies examining patient acceptance of and willingness to pay for pharmacy based point-of-care tests.
11:30 Point-of-Care Diagnostics: Regulatory Perspective
Allison M. Dering-Anderson, BA, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy, University of Nebraska College of Pharmacy
This program will focus on the regulatory and statutory issues that may be encountered by pharmacies conducting Point-of-Care Tests or planning to conduct Point-of-Care Tests. It will also be useful to test manufacturers and developers who are looking to enter the community pharmacy market.
